Bullseye Biosciences - About the company
Bullseye Biosciences is a funded company based in Allston (United States), founded in 2023 by Corey Gray. It operates as an It develops novel therapeutics using directed evolution technology. The company has 1871 active competitors, including 96 funded and 201 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Company Details
It develops novel therapeutics using directed evolution technology. This cutting-edge approach incorporates automation and next-generation sequencing to evolve new medicines. The focus is on addressing challenging drivers of human disease, particularly within cardiometabolic, inflammation, and oncology areas. A team of experts translates scientific advancements into practical medical applications. The company leverages automation and artificial intelligence to enhance its drug discovery process.
- Website
- www.bullseyebiosciences.com/
- Email ID
- *****@bullseye.bio
Key Metrics
Founded Year
2023
Location
Allston, United States
Stage
Funding Raised
Investors
Ranked
898th among 1871 active competitors
Employee Count
5 as on Aug 31, 2026
Legal entities associated with Bullseye Biosciences
Bullseye Biosciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BULLSEYE BIOSCIENCES INC. CIN: 7253810 , United States, Active | Jan 24, 2023 | - | - | - |
Sign up to download Bullseye Biosciences' company profile
Bullseye Biosciences's funding and investors
Bullseye Biosciences is a funded company. Bullseye Biosciences has 1 institutional investor.
View details of Bullseye Biosciences's funding rounds and investors
Bullseye Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Bullseye Biosciences is Corey Gray. Corey Gray is the CEO of Bullseye Biosciences.
Here are the details of Bullseye Biosciences' key team members:
- Corey Gray: Co-Founder & CEO of Bullseye Biosciences.
View details of Bullseye Biosciences's Founder profiles and Board Members
Bullseye Biosciences' employee count trend
Bullseye Biosciences has 5 employees as of Aug 26. Here is Bullseye Biosciences's employee count trend over the years:
Uncover Bullseye Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bullseye Biosciences's Competitors and alternates
Top competitors of Bullseye Biosciences include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Bullseye Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
3rd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
4th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
7th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 | |
898th | Bullseye Biosciences 2023, Allston (United States), Funding Raised | It develops novel therapeutics using directed evolution technology | - | 17/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bullseye Biosciences's competitors? Click here to see the top ones
Bullseye Biosciences's Investments and acquisitions
Bullseye Biosciences has made no investments or acquisitions yet.
Reports related to Bullseye Biosciences
Here is the latest report on Bullseye Biosciences's sector:
Are you a Founder ?
FAQs about Bullseye Biosciences
Explore our recently published companies
- Lednik DP - Unfunded company
- Gill Construction - Nolanville based, 2015 founded, Unfunded company
- Pro Auto Luxe - San Jose based, Unfunded company
- Fh1100 - Unfunded company
- SolarSub - Edinburgh based, 2023 founded, Funding Raised company
- Fit N Well - Germany based, Unfunded company
